Dosol, Rudelin A.

HRN: 20-50-57  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/07/2026
CEFTRIAXONE 1G (VIAL)
07/07/2026
07/14/2026
IV
2g
Q24
Healed Fracture Left Tibia; S/p ORIF Plating 2020 MRH
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: Compliant To Guidelines